Home/Filings/8-K/0001304492-26-000002
8-K//Current report

Anterix Inc. 8-K

Accession 0001304492-26-000002

$ATEXCIK 0001304492operating

Filed

Jan 6, 7:00 PM ET

Accepted

Jan 7, 7:30 AM ET

Size

142.5 KB

Accession

0001304492-26-000002

Research Summary

AI-generated summary of this filing

Updated

Anterix Inc. COO Ryan Gerbrandt to Depart; Role Eliminated

What Happened Anterix Inc. (ATEX) filed an 8-K on January 7, 2026 (Item 5.02) announcing that Chief Operating Officer Ryan Gerbrandt will depart the company effective January 9, 2026. The departure is part of an internal reorganization under which the Chief Operating Officer position is being eliminated.

Key Details

  • Filing date: January 7, 2026; effective departure: January 9, 2026.
  • Executive: Ryan Gerbrandt, Chief Operating Officer.
  • Severance: Mr. Gerbrandt is eligible for severance benefits applicable to a "Legacy Tier 1 Executive" under Anterix’s Executive Severance Plan, subject to his signing a release of claims.
  • Reference: Severance terms referenced are described in the "Severance Arrangements with our NEOs" section of Anterix’s definitive proxy (Schedule 14A) for the 2025 annual meeting filed June 30, 2025.

Why It Matters This 8-K reports an executive-level organizational change that eliminates the COO role and triggers a severance arrangement for the departing officer. For investors, the item is material because leadership changes can affect operations, cost structure (severance expense), and strategic execution. The filing provides no new financial estimates or transactions beyond the severance framework referenced in the company’s 2025 proxy.